Dr. Anita Kohli is a board-certified infectious disease specialist and CEO and Director of Clinical Research at Arizona Liver Health and Arizona Clinical Trials in the state of Arizona. Dr. Kohli has over 18 years of experience in the field of liver disease, treats viral hepatitis and NASH, and leads much of the country’s cutting-edge research in liver disease. She is a nationally and internationally recognized expert in clinical and translational research and has been the lead/principal investigator in multiple studies on various liver conditions as well as numerous publications in respected medical journals including JAMA, Lancet, and the Annals of Internal Medicine. Dr. Kohli sits on many advisory boards related to infectious disease such as viral hepatitis and COVID-19, drug development, and other liver and research development areas.
Dr. Kohli started Arizona Liver Health after serving as the Director of Research, Division of Hepatology and Chair of Research, Department of Internal Medicine, at St Joseph’s Hospital and Medical Center (now Common Spirit) in Phoenix, AZ. Prior to St. Joseph’s, Dr. Kohli was a clinical investigator at The National Institutes of Health, a physician at the National Heart, Lung, and Blood Institute, and completed fellowship in infectious diseases at the National Institutes of Health.
Dr. Kohli’s mission is to focus on innovative clinical care and the pursuit of excellence through scholarly activity and emphasizes academic involvement as part of the clinic culture serving several regions throughout the state. Dr. Kohli provides her patients with most cutting-edge options and exceptional patient experiences, and access to the best and latest state-of-the art treatments and studies.
Dr. Kohli is a member of the American Association of Liver Disease. She is an Adjunct Faculty at the University of Arizona Department of Public Health as well as Division of Infectious Disease and Assistant Professor of Medicine at Creighton University.